Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Tinkoff Bank entered Crimea

2/19/24 T

Kamaz will increase production up to 220 trucks per day

2/19/24 KMAZ

Polymetal postpones dividend decision until May for now

2/19/24 POLY

UGC will free up more than 40 tons of gold for mining

2/19/24 UGLD

Fix Price's operating subsidiary reported by RAS

2/19/24 FIXP

M&A deals of Mosgorlombard will be financed by Promsvyazbank

2/19/24 MGKL

M.Video attracts strangers to its service areas

2/19/24 MVID

Kamaz cedes leadership to China's Sitrak

2/19/24 KMAZ

Polymetal agreed to sell Russian assets

2/19/24 POLY

Sovcombank will allocate 30% of 2023 profit for dividends

2/16/24 SVCB